Last reviewed · How we verify
Research Bloods (research-bloods)
At a glance
| Generic name | research-bloods |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Platelet Rich Plasma Injections In Young And Old Human Subjects (PHASE2)
- De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
- The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss
- The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer (NA)
- Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG (PHASE2)
- Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer (PHASE1, PHASE2)
- REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study (PHASE2)
- Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management Across the European Union (PERFORM)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Research Bloods CI brief — competitive landscape report
- Research Bloods updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI